{
  "regulatory_reporting": {
    "ifrs_17_reporting": {
      "contract_groups_summary": {
        "total_contract_groups": 5,
        "total_liability": 495000000,
        "total_csrm": 12000000,
        "measurement_models": {
          "building_block_approach": 4,
          "premium_allocation_approach": 1
        }
      },
      "liability_measurement": {
        "fulfillment_cash_flows": {
          "expected_payments": 248000000,
          "expected_receipts": 277000000,
          "risk_adjustment": 12000000,
          "discount_effect": 8000000
        },
        "csrm_development": {
          "opening_balance": 10000000,
          "acquisition_costs": 8000000,
          "releases": 6000000,
          "closing_balance": 12000000
        }
      },
      "transition_effects": {
        "transition_date": "2023-01-01",
        "opening_balance_adjustment": 15000000,
        "cumulative_adjustment": 20000000,
        "retrospective_application": "Not Applied"
      },
      "disclosures": {
        "risk_exposures": "Comprehensive",
        "sensitivity_analysis": "Completed",
        "reconciliation": "Available",
        "assumptions": "Documented"
      }
    },
    "solvency_ii_reporting": {
      "solvency_capital_requirement": {
        "bscr": 150000000,
        "adjustments": 15000000,
        "total_scr": 135000000,
        "risk_modules": {
          "market_risk": 85000000,
          "counterparty_default_risk": 20000000,
          "life_underwriting_risk": 33000000,
          "non_life_underwriting_risk": 75000000,
          "health_underwriting_risk": 15000000,
          "operational_risk": 10000000
        },
        "diversification_effects": -45000000
      },
      "minimum_capital_requirement": {
        "mcr": 75000000,
        "mcr_ratio": 0.5,
        "mcr_components": {
          "technical_provisions": 60000000,
          "operational_expenses": 15000000
        }
      },
      "own_funds": {
        "basic_own_funds": 200000000,
        "ancillary_own_funds": 25000000,
        "total_own_funds": 225000000,
        "eligible_own_funds": 200000000,
        "solvency_ratio": 1.48,
        "mcr_ratio": 2.67
      }
    },
    "quarterly_reporting": {
      "q1_2024": {
        "reporting_date": "2024-03-31",
        "solvency_ratio": 1.52,
        "mcr_ratio": 2.80,
        "key_metrics": {
          "total_assets": 520000000,
          "total_liabilities": 495000000,
          "own_funds": 25000000
        }
      },
      "q2_2024": {
        "reporting_date": "2024-06-30",
        "solvency_ratio": 1.49,
        "mcr_ratio": 2.73,
        "key_metrics": {
          "total_assets": 515000000,
          "total_liabilities": 490000000,
          "own_funds": 25000000
        }
      },
      "q3_2024": {
        "reporting_date": "2024-09-30",
        "solvency_ratio": 1.46,
        "mcr_ratio": 2.65,
        "key_metrics": {
          "total_assets": 510000000,
          "total_liabilities": 485000000,
          "own_funds": 25000000
        }
      },
      "q4_2024": {
        "reporting_date": "2024-12-31",
        "solvency_ratio": 1.48,
        "mcr_ratio": 2.67,
        "key_metrics": {
          "total_assets": 520000000,
          "total_liabilities": 495000000,
          "own_funds": 25000000
        }
      }
    },
    "annual_reporting": {
      "2023": {
        "reporting_period": "2023-01-01 to 2023-12-31",
        "annual_solvency_report": "Submitted",
        "audit_opinion": "Unqualified",
        "regulatory_findings": "No Material Issues",
        "key_developments": [
          "IFRS 17 implementation completed",
          "Solvency II compliance maintained",
          "Risk management framework enhanced"
        ]
      },
      "2024": {
        "reporting_period": "2024-01-01 to 2024-12-31",
        "annual_solvency_report": "In Progress",
        "audit_opinion": "Pending",
        "regulatory_findings": "Pending",
        "key_developments": [
          "Enhanced stress testing implemented",
          "Climate risk assessment initiated",
          "Digital transformation continued"
        ]
      }
    },
    "stress_testing": {
      "regulatory_stress_tests": {
        "eiopa_stress_test": {
          "participation": "Yes",
          "results": "Within tolerance",
          "capital_impact": -30000000
        },
        "national_stress_test": {
          "participation": "Yes",
          "results": "Within tolerance",
          "capital_impact": -25000000
        }
      },
      "internal_stress_tests": {
        "market_risk_scenarios": {
          "interest_rate_shock": -40000000,
          "equity_market_crash": -60000000,
          "credit_spread_widening": -30000000
        },
        "insurance_risk_scenarios": {
          "catastrophe_event": -50000000,
          "mortality_shock": -20000000,
          "longevity_improvement": -15000000
        }
      }
    },
    "compliance_monitoring": {
      "regulatory_requirements": {
        "ifrs_17_compliance": "Compliant",
        "solvency_ii_compliance": "Compliant",
        "local_regulations": "Compliant"
      },
      "reporting_deadlines": {
        "quarterly_reports": "Met",
        "annual_reports": "Met",
        "stress_test_reports": "Met"
      },
      "audit_findings": {
        "external_audit": "Clean opinion",
        "internal_audit": "Minor findings",
        "regulatory_inspections": "No issues"
      }
    }
  },
  "data_quality": {
    "completeness": 0.98,
    "accuracy": 0.95,
    "timeliness": 0.99,
    "consistency": 0.97,
    "validation_status": "Passed",
    "last_validation_date": "2024-12-19T10:00:00Z"
  },
  "metadata": {
    "reporting_date": "2024-12-19T10:00:00Z",
    "data_version": "1.0",
    "description": "Comprehensive prototype data for regulatory reporting testing and development"
  }
}
